EX-99.1 2 exhibit1.htm EX-99.1 EX-99.1

Exhibit 99.1

FY09 EPS Reconciliation for Regulation G Purposes

                         
 
   Q1   Q2   Q3   Q4        Fiscal Year
Total
 
                        
Diluted EPS from continuing operations
  $  0.23   $  0.38   $  0.43                  
Items impacting comparability:
                **         **
Expense (benefit) related to mark-to-market impact of derivatives
     0.04*      0.06*      (0.05)*                   
Gain on sale of Pemmican brand
     (0.02)*                            
Expense related to restructuring charges, continuing operations
     0.02*                            
Expense related to peanut butter legal matters
              0.03*                    
Benefit of lower than normal tax rate
              (0.01)*      (0.01)*                    
 
                        
Diluted EPS excluding items impacting comparability
        
$   0.27 		         
$   0.43 		        
$   0.40 		  Slightly
above
$  0.40 		      Slightly
above
$  1.50
 
                        

* Items affecting comparability are each rounded to the nearest penny.

 * * The timing and amount of items impacting comparability cannot be determined at this time.